EUVIMEDObjevte EUVIMED
Crossref

Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod‐like receptor family pyrin domain‐containing 3/caspase‐1/Gasdermin E mediated pyroptosis pathway

Peng-Peng Xu, Jie Wu, Jing Zhang, Tian-Yue Yu, Yu-Bin Wang

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14325 ↗

At a glance

Journal article in Chemical Biology & Drug Design, 2024. Written by Peng-Peng Xu and 4 co-authors. Institution: Suzhou Medical College of Soochow University. Suzhou, Jiangsu, China. Major MEDLINE topics: NLR Family, Pyrin Domain-Containing 3 Protein, Stomach Neoplasms. Cited 7 times so far (Crossref); 27 references.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Gastric cancer (GC) is a gastric epithelium‐derived malignancy insensitive to post‐surgical radiotherapy. Paclitaxel, an anti‐microtubule drug, has been proven to induce apoptosis of GC cells; however, its exact mechanism of action is unclear. Therefore, the molecular mechanism by which paclitaxel inhibits the proliferation, migration and invasion of GC cells was investigated in this study. First off, SNU‐719 cells were co‐cultured with paclitaxel and/or Caspase1 inhibitor VX765. Then the proliferation ability of the cells was detected by MTT after paclitaxel treatment (0, 10, 20, 40, and 80 nM), the migration ability by scratch assay, and the invasion ability by Transwell assay. Next, the levels of interleukin (IL)‐1β and IL‐18 in cell culture supernatant were detected by the enzyme linked immunosorbent assay (ELISA). And the level of lactate dehydrogenase (LDH) in the supernatant was measured by a corresponding kit. Finally, western blot was performed to detect the concentrations of Gasdermin E (GSDME), GSDME‐N, nod‐like receptor family pyrin domain‐containing 3 (NLRP3), caspase‐1, cleaved caspase‐1 protein in GC cells. As a result, paclitaxel inhibited the proliferation, migration, and invasion of SNU‐719 cells in a concentration‐dependent manner. Moreover, it induced the pyroptosis of SNU‐719 cells. After cell co‐culture with VX765 paclitaxel showed decreased inhibitory effect on the migration and invasion of SNU‐719 cells. VX765, additionally, suppressed the NLRP3/caspase‐1/GSDME mediated pyroptosis pathway activated by paclitaxel. In a nutshell, paclitaxel may inhibit the migration and invasion of GC cells SNU‐719 through the NLRP3/caspase‐1/GSDME mediated pyroptosis pathway.

Subjects

MeSH terms (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinStomach NeoplasmsHumansPyroptosisNLR ProteinsCaspase 1PaclitaxelGasderminsPyrin Domain

Author keywords

gastric cancerinvasionmigrationpaclitaxelpyroptosisthe nod-like receptor family pyrin domain-containing 3/caspase-1/Gasdermin E pa…

Substances

NLR Family, Pyrin Domain-Containing 3 ProteinNLR ProteinsCaspase 1PaclitaxelGasdermins

Authors and institutions

  • Suzhou Medical College of Soochow University. Suzhou, Jiangsu, China.
  • Department of Medical Oncology, The First Affiliated Hospital of Jin Zhou Medical University. Jinzhou, Liaoning, China.
  • Department of General Surgery, The First Affiliated Hospital of Jin Zhou Medical University. Jinzhou, Liaoning, China.

Cite

APA

Xu, P. P., Wu, J., Zhang, J., Yu, T. Y., & Wang, Y. B. (2024). Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod‐like receptor family pyrin domain‐containing 3/caspase‐1/Gasdermin E mediated pyroptosis pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14325

Vancouver

Xu PP, Wu J, Zhang J, Yu TY, Wang YB. Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod‐like receptor family pyrin domain‐containing 3/caspase‐1/Gasdermin E mediated pyroptosis pathway. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14325

BibTeX
@article{Xu2024,
  author = {Xu, Peng-Peng and Wu, Jie and Zhang, Jing and Yu, Tian-Yue and Wang, Yu-Bin},
  title = {Paclitaxel may inhibit migration and invasion of gastric cancer cells via nod‐like receptor family pyrin domain‐containing 3/caspase‐1/Gasdermin E mediated pyroptosis pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14325}
}
Start for free →